Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Kamp

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Plos One|October 6, 2021
COVID-19 in lung transplant recipients-Risk prediction and outcomesJan C Kamp, Jan B Hinrichs, Jan Fuge, et al.
BMC Pulmonary Medicine|May 16, 2021
Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertensionJan C Kamp, Jan Fuge, Jan F Karsten, et al.
Frontiers in Psychiatry|March 14, 2022
Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial HypertensionDa-Hee Park, Tanja Meltendorf, Kai G Kahl, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Pharmacokinetics of Meropenem in People with Cystic Fibrosis-A Proof of Concept Clinical TrialJan C Kamp, Jan Fuge, Felix C Ringshausen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 27, 2019
Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertensionKaren M Olsson, Manuel J Richter, Jan C Kamp, et al.
Pulmonary Circulation|June 8, 2026
Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With SotaterceptJan Fuge, Karen M Olsson, Kira Remmert, et al.
Frontiers in Psychiatry|February 25, 2022
Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center StudyJan Fuge, Da-Hee Park, Thomas von Lengerke, et al.
Physics in Medicine and Biology|May 11, 2023
Human lung virtual histology by multi-scale x-ray phase-contrast computed tomographyJakob Reichmann, Stijn E Verleden, Mark Kühnel, et al.
International Journal of Cardiology|July 8, 2020
Blood carbon dioxide tension and risk in pulmonary arterial hypertensionLars Harbaum, Jan Fuge, Jan C Kamp, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Plos One|October 6, 2021
COVID-19 in lung transplant recipients-Risk prediction and outcomesJan C Kamp, Jan B Hinrichs, Jan Fuge, et al.
BMC Pulmonary Medicine|May 16, 2021
Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertensionJan C Kamp, Jan Fuge, Jan F Karsten, et al.
Frontiers in Psychiatry|March 14, 2022
Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial HypertensionDa-Hee Park, Tanja Meltendorf, Kai G Kahl, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Pharmacokinetics of Meropenem in People with Cystic Fibrosis-A Proof of Concept Clinical TrialJan C Kamp, Jan Fuge, Felix C Ringshausen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 27, 2019
Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertensionKaren M Olsson, Manuel J Richter, Jan C Kamp, et al.
Pulmonary Circulation|June 8, 2026
Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With SotaterceptJan Fuge, Karen M Olsson, Kira Remmert, et al.
Frontiers in Psychiatry|February 25, 2022
Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center StudyJan Fuge, Da-Hee Park, Thomas von Lengerke, et al.
Physics in Medicine and Biology|May 11, 2023
Human lung virtual histology by multi-scale x-ray phase-contrast computed tomographyJakob Reichmann, Stijn E Verleden, Mark Kühnel, et al.
International Journal of Cardiology|July 8, 2020
Blood carbon dioxide tension and risk in pulmonary arterial hypertensionLars Harbaum, Jan Fuge, Jan C Kamp, et al.
Pageof 4